Literature DB >> 23550956

Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76.

Christoph Gassner1, Irene Utz, Harald Schennach, Angela Ramoni, Hannes Steiner, Sabine Scholz, Ursula Kreklau, Günther F Körmöczi.   

Abstract

BACKGROUND: Molecular variant RHD allele analysis is best complemented by detailed characterization of the associated D phenotype. STUDY DESIGN AND METHODS: Variant D types were characterized using molecular typing, RHD sequencing, extended serologic D antigen investigations, and flow cytometric D antigen quantification.
RESULTS: We discovered three novel weak D types termed weak D Types 45.1, 75, and 76 with RHD nucleotide substitutions coding for amino acid exchanges in predicted intracellular RhD polypeptide stretches; antigen densities of approximately 1.990, 900, and 240 D sites per red blood cell were found, respectively. Adsorption-elution technique-supported D epitope mapping of these three weak D types demonstrated the expression of all tested D epitopes. Initial molecular typing of the three investigated samples by RHD gene exon scanning polymerase chain reaction using sequence-specific priming yielded a negative reaction for A1193 located in RHD Exon 9 and could be explained by specific mutations for weak D Types 45.1 (C818T, G1195A), 75 (G1194C), and 76 (A1215C).
CONCLUSION: All novel weak D types expressed all tested D epitopes. It is of interest that for weak D Types 45.1, 75, and 76, similar alleles with a maximal divergence of one amino acid only, that is, weak D Types 45, 41, and 68, respectively, have been reported so far.
© 2013 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23550956     DOI: 10.1111/trf.12180

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expression.

Authors:  Eva Maria Matzhold; Helene Polin; Günther F Körmöczi; Susanne Macher; Marlies Schönbacher; Thomas Wagner
Journal:  Transfusion       Date:  2019-07-23       Impact factor: 3.157

2.  Aberrant ABO B Phenotype with Irregular Anti-B Caused by a Para-Bombay FUT1 Mutation.

Authors:  Eva Maria Matzhold; Thomas Wagner; Camilla Drexler; Marlies Schönbacher; Günther F Körmöczi
Journal:  Transfus Med Hemother       Date:  2019-04-29       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.